DYN - Latest News
Dyne Therapeutics, Inc. (DYN), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $4.80B. Beta to the broader market is 1.08.
The article list below shows the most recent DYN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent DYN Headlines
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com - Jul 29, 2026
- Biologics License Application (BLA) for z-rostudirsen in exon 51 DMD accepted for review by FDA; Priority Review granted; PDUFA target action date s
Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
globenewswire.com - Jul 28, 2026
- Company's third program to enter clinical development leveraging FORCE platform with the goal of delivering functional improvement in rare neuromusc
Fifth Third Bancorp Buys New Shares in Dyne Therapeutics, Inc. $DYN
defenseworld.net - Jul 27, 2026
Fifth Third Bancorp purchased a new stake in Dyne Therapeutics, Inc. (NASDAQ: DYN) during the undefined quarter, according to its most recent filing
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - Jul 24, 2026
WALTHAM, Mass. , July 24, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
globenewswire.com - Jul 23, 2026
WALTHAM, Mass. , July 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.
How News Affects DYN Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track DYN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked DYN news questions
- What is the latest DYN news headline?
- The most recent DYN headline (Jul 29, 2026) is "Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the DYN news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What DYN news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual DYN options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.